TRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitro

PLoS One. 2011 Jan 14;6(1):e14527. doi: 10.1371/journal.pone.0014527.


Background: Signaling by Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) and Fas ligand (FasL) has been proposed to contribute to the chemosensitivity of tumor cells treated with various other anti-cancer agents. However, the importance of these effects and whether there are differences in vitro and in vivo is unclear.

Methodology/principal findings: To assess the relative contribution of death receptor pathways to this sensitivity and to determine whether these effects are intrinsic to the tumor cells, we compared the chemosensitivity of isogenic BJAB human lymphoma cells where Fas and TRAIL receptors or just TRAIL receptors were inhibited using mutants of the adaptor protein FADD or by altering the expression of the homeobox transcription factor Six1. Inhibition of TRAIL receptors did not affect in vitro tumor cell killing by various anti-cancer agents indicating that chemosensitivity is not significantly affected by the tumor cell-intrinsic activation of death receptor signaling. However, selective inhibition of TRAIL receptor signaling caused reduced tumor regression and clearance in vivo when tested in a NOD/SCID mouse model.

Conclusions: These data show that TRAIL receptor signaling in tumor cells can determine chemosensitivity in vivo but not in vitro and thus imply that TRAIL resistance makes tumors less susceptible to conventional cytotoxic anti-cancer drugs as well as drugs that directly target the TRAIL receptors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm*
  • Fas Ligand Protein
  • Humans
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Mice
  • Mice, SCID
  • Neoplasm Transplantation
  • Receptors, TNF-Related Apoptosis-Inducing Ligand / metabolism
  • Receptors, TNF-Related Apoptosis-Inducing Ligand / physiology*
  • Signal Transduction*


  • Antineoplastic Agents
  • Fas Ligand Protein
  • Receptors, TNF-Related Apoptosis-Inducing Ligand